Advisory Services Network, LLC Genfit S.A. Transaction History

Advisory Services Network, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	BUY	$2.97 - $3.94 $297 - $394	100 New	100 $0
Q4 2022 Feb 13, 2023	BUY	$3.53 - $4.39 $353 - $438	100 New	100 $0
Q3 2021 Nov 05, 2021	SELL	$3.58 - $4.14 $358 - $413	-100 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$3.8 - $4.63 $380 - $463	100 New	100 $0
Q1 2021 May 24, 2021	SELL	$4.53 - $6.06 $453 - $606	-100 Closed	0 $0

Q3 2020 Nov 16, 2020	BUY	$3.67 - $5.59 $367 - $559	100 New	100 $1,000
Q2 2020 Aug 10, 2020	SELL	$5.2 - $22.0 $520 - $2,200	-100 Closed	0 $0
Q4 2019 Feb 04, 2020	BUY	$13.55 - $20.14 $1,355 - $2,014	100 New	100 $2,000

76.8K

Ticker GNFT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,815,500
Market Cap $207M
Description
Genfit S.A., a biopharmaceutical company, discovers and develops drug candidates and diagnostic solutions for metabolic and liver-related diseases. The company's products include Elafibranor, which is in Phase 3 clinical trial to treat patients with primary biliary cholangitis. It also engages in the development of NIS4 technology for the diagno...

Get notified when there are updates to the investment portfolio of Advisory Services Network, LLC, based on Form 13F filings with the SEC.

Stay updated on Advisory Services Network, LLC with notifications on news.